J Pediatr. 2004 Oct;145(4):555-60.

Long-term follow-up of well-treated nephropathic cystinosis patients.

Kleta R, Bernardini I, Ueda M, Varade WS, Phornphutkul C, Krasnewich D, Gahl WA.

Source

Section on Human Biochemical Genetics, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892-1851, USA. kletar@mail.nih.gov <kletar@mail.nih.gov>

Abstract

We report the excellent clinical outcomes of siblings with nephropathic cystinosis treated diligently with cysteamine starting at 20 months and 2 months of age. Now 15 and 8 years old, they have glomerular filtration rates of 78 and 105 mL/min/1.73m 2 , respectively. These cases illustrate the critical importance of early diagnosis and treatment.

Comment in

J Pediatr. 2004 Oct;145(4):436-8.

PMID:: 15480385; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Case Reports

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

CYSTEAMINE - HSDB

Supplemental Content

Related citations

Nephropathic cystinosis in children: An overlooked disease. [Saudi J Kidney Dis Transpl. 2009]
Nephropathic cystinosis in children: An overlooked disease.
Soliman NA, El-Baroudy R, Rizk A, Bazaraa H, Younan A. Saudi J Kidney Dis Transpl. 2009 May; 20(3):436-42.
Review Pharmacological treatment of nephropathic cystinosis with cysteamine. [Expert Opin Pharmacother. 2004]
Review Pharmacological treatment of nephropathic cystinosis with cysteamine.
Kleta R, Gahl WA. Expert Opin Pharmacother. 2004 Nov; 5(11):2255-62.
Parenchymal organ cystine depletion with long-term cysteamine therapy. [Biochem Med Metab Biol. 1992]
Parenchymal organ cystine depletion with long-term cysteamine therapy.
Gahl WA, Charnas L, Markello TC, Bernardini I, Ishak KG, Dalakas MC. Biochem Med Metab Biol. 1992 Dec; 48(3):275-85.
Review Early oral cysteamine therapy for nephropathic cystinosis. [Eur J Pediatr. 2003]
Review Early oral cysteamine therapy for nephropathic cystinosis.
Gahl WA. Eur J Pediatr. 2003 Dec; 162 Suppl 1:S38-41. Epub 2003 Nov 11.
Review NIH conference. Cystinosis: progress in a prototypic disease. [Ann Intern Med. 1988]
Review NIH conference. Cystinosis: progress in a prototypic disease.
Gahl WA, Thoene JG, Schneider JA, O'Regan S, Kaiser-Kupfer MI, Kuwabara T. Ann Intern Med. 1988 Oct 1; 109(7):557-69.

See reviews... See all...

Cited by 3 PubMed Central articles

Review Cystinosis: practical tools for diagnosis and treatment. [Pediatr Nephrol. 2011]
Review Cystinosis: practical tools for diagnosis and treatment.
Wilmer MJ, Schoeber JP, van den Heuvel LP, Levtchenko EN. Pediatr Nephrol. 2011 Feb; 26(2):205-15. Epub 2010 Aug 24.
Pharmacokinetics of enteric-coated cysteamine bitartrate in healthy adults: a pilot study. [Br J Clin Pharmacol. 2010]
Pharmacokinetics of enteric-coated cysteamine bitartrate in healthy adults: a pilot study.
Gangoiti JA, Fidler M, Cabrera BL, Schneider JA, Barshop BA, Dohil R. Br J Clin Pharmacol. 2010 Sep; 70(3):376-82.
Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase. [J Clin Invest. 2006]
Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase.
Borrell-Pagès M, Canals JM, Cordelières FP, Parker JA, Pineda JR, Grange G, Bryson EA, Guillermier M, Hirsch E, Hantraye P, et al. J Clin Invest. 2006 May; 116(5):1410-24. Epub 2006 Apr 6.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Long-term follow-up of well-treated nephropathic cystinosis patients.
Long-term follow-up of well-treated nephropathic cystinosis patients.
J Pediatr. 2004 Oct ;145(4):555-60.

PubMed
Febrile seizures: an update.
Febrile seizures: an update.
Arch Dis Child. 2004 Aug ;89(8):751-6.

PubMed
Do neck levels negative on initial CT need to be dissected after definitive radi...
Do neck levels negative on initial CT need to be dissected after definitive radiation therapy with or without chemotherapy?
Head Neck. 2008 Aug ;30(8):1090-8.

PubMed
Triple-transgenic Alzheimer's disease mice exhibit region-specific abnormalities...
Triple-transgenic Alzheimer's disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology.
Glia. 2009 Jan 1 ;57(1):54-65.

PubMed
Evaluation of a multiple-cycle, recombinant virus, growth competition assay that...
Evaluation of a multiple-cycle, recombinant virus, growth competition assay that uses flow cytometry to measure replication efficiency of human immunodeficiency virus type 1 in cell culture.
J Clin Microbiol. 2006 Jun ;44(6):1930-43.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: